IONS · Ionis Pharmaceuticals Inc · Investor Relations

$29.06 +1.75 (+6.41%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript

Russell 1000 member Rebalance outlook locked

Market Cap

$4.84B

166.55M

Volume · Nov 13 5.95M Avg daily vol (3M) 3.8M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date	Headline
2026-11-02	Ionis to hold third quarter 2026 financial results webcast
2026-09-22	Ionis announces positive topline results from Phase 3 FUSION study of ulefnersen marking significant milestone in advancing first potential disease modifying treatment for FUS-ALS

Past events

Date	Event	Type
2026-11-09	Ionis Pharmaceuticals Inc Q3 FY2026 Earnings Call	Earnings call
2026-09-16	Morgan Stanley 24th Annual Global Healthcare Conference	Conference
2026-09-10	Wells Fargo 21st Annual Healthcare Conference	Conference
2026-09-04	ZANVASTRO TM (zilganersen) FDA Approval Webcast	Webcast
2026-07-29	Second Quarter 2026 Financial Results Webcast	Earnings call
2026-06-24	TRYNGOLZA™ (olezarsen) FDA sHTG Approval Webcast	Webcast
2026-06-14	Endocrine Society’s annual meeting	Shareholder meeting
2026-06-12	National Lipid Association (NLA) Scientific Sessions	Event
2026-06-10	Goldman Sachs 47th Annual Global Healthcare Conference	Conference
2026-06-06	2026 Scientific Sessions of the American Diabetes Association® (ADA)	Event
2026-06-04	2026 Virtual Annual Meeting of Stockholders Corporate Presentation	Shareholder meeting
2026-05-19	2026 RBC Capital Markets Global Healthcare Conference	Conference
2026-05-12	Bank of America Securities 2026 Health Care Conference	Conference
2026-04-29	First Quarter 2026 Financial Results Webcast	Earnings call
2026-02-25	Earnings conference call (announced in 8-K)	Earnings call

Source: https://ir.ionispharma.com/

Key facts CIK 874015 CUSIP 462222100 13F (30d) 363 filings 328 filers Visit website Investor relations